The Manila Times

Myriad Genetics Receives FDA Approval of the MyChoice CDx Test as the Companion Diagnostic for Zejula (niraparib) for Patients with Ovarian Cancer

Approval reinforces Myriad’s leadership in comprehensive HRD testing and establishes MyChoice CDx as the only FDA-approved ...

Meet the Biohacker Measuring Her Ovarian Age—And Taking a New Test to Predict Menopause

As an eager tester of new therapies to reduce her biological age, or how fast she is aging internally, Barnes-Lentz thrives on collecting more data about her health. It’s especially important for her ...

Myriad's Diagnostic Test for Ovarian Cancer Treatment Gets FDA Approval

Myriad Genetics received approval for a diagnostic test aimed at identifying advanced ovarian cancer patients eligible for treatment with Zejula from the Food and Drug Administration.
Pharmabiz

Myriad Genetics receives US FDA approval for MyChoice CDx test as companion diagnostic for Zejula for patients with ovarian cancer

Myriad Genetics receives US FDA approval for MyChoice CDx test as companion diagnostic for Zejula for patients with ovarian cancer: Salt Lake City Thursday, March 19, 2026, 15:00 ...

Myriad Genetics, Inc.: Myriad Genetics Receives FDA Approval of the MyChoice CDx Test as the Companion Diagnostic for Zejula (niraparib) for Patients with Ovarian Cancer

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that the U.S. Food and Drug ...
ET HealthWorld

AMH based blood test aims to simplify PCOS diagnosis, Improves early detection

Discover the groundbreaking Elecsys® AMH Plus blood test by Redcliffe Labs and Roche Diagnostics India that offers an easier, less invasive way to diagnose Polycystic Ovary Syndrome (PCOS), ensuring ...

Ovarian cancer symptoms may be vague, but physician visit important

Vague is a word frequently used to describe symptoms of ovarian cancer. However, if there are key and persistent signs that last more than two or three weeks, it likely would be wise to see a ...

Stirling survivor makes ovarian cancer awareness push ahead of spotlight month

March is Ovarian Cancer Awareness Month - but one local survivor has called for greater understanding of the condition which ...
Express Healthcare

Redcliffe Labs launches Elecsys AMH Plus test with Roche Diagnostics India for PCOS diagnosis

Redcliffe Labs has launched the Elecsys AMH Plus blood test in collaboration with Roche Diagnostics India to support identification of Polycystic Ovarian Morphology (PCOM) and aid in the diagnosis of ...
Neos Kosmos

“Listen to your body”: Melbourne mother after surviving ovarian cancer

"Don't ignore symptoms, even the smallest one." Irene Koulogeorgiou's story highlights the silent nature of ovarian cancer ...
CURE

Keytruda Combo Extends Survival in Ovarian Cancer Trial: Expert Insights

Pembrolizumab plus weekly paclitaxel, with investigator-choice bevacizumab, achieved statistically significant PFS and OS improvements, addressing a high unmet need in platinum-resistant ovarian ...

Hard-to-diagnose women’s disease is often dismissed, even by gynecologists — but can cause serious problems if left untreated

Dr. Sheeva Talebian is haunted by how long “we’ve conditioned women to believe that debilitating pain is normal.” It’s a “clinical failure,” she declared, and it’s a reason why symptoms of one tricky ...